DES, BMS or DCB: What is the best option for long complex lesions in the SFA?
Sabine Steiner and Yann Gouëffic delve into the pivotal preliminary findings of the SPORTS trial, revealed at the TCT 2023 Congress and discussed during the PVI 2023 Course, which scrutinized and compared the efficacy of Drug-Eluting Stents (DES), Bare Metal Stents (BMS), and Drug-Coated Balloons (DCB) in patients with TASC C/D SFA lesions.
As they discuss these results, they navigate through the nuances of each technique, dissecting the advantages, limitations, and implications for clinical practice, highlighting the boundaries of the trial too.
Watch this short video interview to find out more!
Professor of Vascular Surgery
President of the association of the french university hospitals for clinical research
Conflicts of interest:
Research funding from Predisurge, Biotronik, WL Gore, GE Healthcare
Honoraria from Abbott, BD, Bentely, Biotronik, Boston Scientific, Cook, Eclevar Medtech, GE Healthcare, Ivascular, Medtronic, Penumbra, Sensome, Shockwave medical, WL Gore (consulting, medical advisory board, educational course, speaking)
